+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Protein Drugs"

Recombinant Proteins Market - Product Thumbnail Image

Recombinant Proteins Market

  • Report
  • June 2024
  • 108 Pages
  • Global
From
From
From
Protein Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Protein Therapeutics - Global Strategic Business Report

  • Report
  • March 2025
  • 181 Pages
  • Global
From
Recombinant Proteins Market Report 2025 - Product Thumbnail Image

Recombinant Proteins Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
Recombinant Protein Market Report and Forecast 2024-2032 - Product Thumbnail Image

Recombinant Protein Market Report and Forecast 2024-2032

  • Report
  • August 2024
  • 200 Pages
  • Global
From
Protein Therapeutics Market 2024-2028 - Product Thumbnail Image

Protein Therapeutics Market 2024-2028

  • Report
  • May 2024
  • 191 Pages
  • Global
From
Recombinant Proteins Market 2024-2028 - Product Thumbnail Image

Recombinant Proteins Market 2024-2028

  • Report
  • July 2024
  • 178 Pages
  • Global
From
From
Single-use Technologies for Biopharmaceuticals Market - Product Thumbnail Image

Single-use Technologies for Biopharmaceuticals Market

  • Report
  • November 2024
  • 207 Pages
  • Global
From
PEGylated Proteins Market 2023-2028 - Product Thumbnail Image

PEGylated Proteins Market 2023-2028

  • Report
  • April 2024
  • 74 Pages
  • Global
From
Loading Indicator

The Protein Drugs market is a subset of the larger Drug Discovery industry. It focuses on the development of drugs that are based on proteins, such as monoclonal antibodies, cytokines, and growth factors. These drugs are used to treat a variety of diseases, including cancer, autoimmune disorders, and infectious diseases. Protein drugs are typically developed through recombinant DNA technology, which involves the manipulation of genetic material to create a desired protein. The Protein Drugs market is highly competitive, with many companies vying for a share of the market. Companies in the market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are engaged in research and development of new protein drugs, as well as the marketing and distribution of existing drugs. Show Less Read more